Cingulate Inc. (NASDAQ:CINGW) Short Interest Up 405.4% in April

Cingulate Inc. (NASDAQ:CINGW) saw a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 11,190 shares, a growth of 405.4% from the April 15th total of 2,214 shares. Based on an average trading volume of 15,395 shares, the short-interest ratio is presently 0.7 days.

Cingulate Trading Up 5.0%

NASDAQ:CINGW traded up $0.00 during midday trading on Thursday, reaching $0.02. 18,310 shares of the stock traded hands, compared to its average volume of 41,701. Cingulate has a 12-month low of $0.02 and a 12-month high of $0.18. The business has a 50-day moving average of $0.03 and a two-hundred day moving average of $0.05.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.